8-K: Selectis Health Appoints James Creamer as Chief Financial Officer

Selectis Health has appointed James Creamer as its new Chief Financial Officer, effective August 15, 2024.

Summary

• Selectis Health, Inc. has appointed James Creamer as Chief Financial Officer.
• The appointment was approved by the Board of Directors on August 27, 2024.
• Mr. Creamer's appointment is effective as of August 15, 2024.
• He previously served as the Interim CEO since December 2023.
• Mr. Creamer's base salary will be $180,000 per year.
• The terms of his engagement are detailed in an offer letter filed as an exhibit.

Sentiment

Score: 7

Explanation: The appointment of a permanent CFO is a positive step for the company, indicating stability and forward progress. The sentiment is positive but not overly enthusiastic as it is a routine corporate action.

Positives

• The appointment of a permanent CFO provides stability to the company's leadership.
• James Creamer has prior experience with the company as Interim CEO, ensuring a smooth transition.

Industry Context

Executive appointments are a normal part of corporate operations, and this appointment is a key step in establishing a stable management team for Selectis Health.

Comparison to Industry Standards

• Executive compensation for CFO roles in similar sized companies typically includes a base salary, stock options, and other benefits.
• The base salary of $180,000 is within the range for CFOs at small to mid-sized companies, but the total compensation package would need to be reviewed to make a full comparison.

Management Changes

Stakeholder Impact

• Shareholders may view the appointment of a permanent CFO as a positive sign of stability and good governance.
• Employees may benefit from having a permanent CFO in place.

Key Dates

Keywords

Chief Financial Officer, CFO, executive appointment, management change, Selectis Health, James Creamer